The global market for Optical Preclinical Imaging is estimated at US$627.4 Million in 2023 and is projected to reach US$936.9 Million by 2030, growing at a CAGR of 5.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Optical Preclinical Imaging Market]( "Optical Preclinical Imaging Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Bioluminescence / Fluorescence Imaging Systems segment, which is expected to reach US$536.9 Million by 2030 with a CAGR of a 7%. The Standalone Fluorescence Imaging Systems segment is also set to grow at 5% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $164 Million in 2023, and China, forecasted to grow at an impressive 9.2% CAGR to reach $220.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Optical Preclinical Imaging Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Optical Preclinical Imaging Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Optical Preclinical Imaging Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as BioTek Instruments, Inc., Bruker Corporation, Fujifilm Holdings America Corporation, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 42 Featured):
- BioTek Instruments, Inc.
- Bruker Corporation
- Fujifilm Holdings America Corporation
- Fujifilm Holdings Corporation
- Magnetic Insight, Inc.
- MBF Bioscience
- Mediso Ltd.
- MILabs B.V.
- Miltenyi Biotec
- MR Solutions
- PerkinElmer, Inc.
- TriFoil Imaging
- UVP
- Vieworks Co., Ltd.
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Global Economic Update
- Optical Preclinical Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 10: World Optical Preclinical Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- Table 11: World Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 12: World Historic Review for Optical Preclinical Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 13: World 16-Year Perspective for Optical Preclinical Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- Table 14: World Recent Past, Current & Future Analysis for Bioluminescence / Fluorescence Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 15: World Historic Review for Bioluminescence / Fluorescence Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 16: World 16-Year Perspective for Bioluminescence / Fluorescence Imaging Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 17: World Recent Past, Current & Future Analysis for Standalone Fluorescence Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 18: World Historic Review for Standalone Fluorescence Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 19: World 16-Year Perspective for Standalone Fluorescence Imaging Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 20: World Recent Past, Current & Future Analysis for Optical + X-Ray / Optical + CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 21: World Historic Review for Optical + X-Ray / Optical + CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 22: World 16-Year Perspective for Optical + X-Ray / Optical + CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
UNITED STATES
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 23: USA Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 24: USA Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 25: USA 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 26: USA Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 27: USA Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 28: USA 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
CANADA
- Table 29: Canada Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 30: Canada Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 31: Canada 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 32: Canada Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 33: Canada Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 34: Canada 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
JAPAN
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 35: Japan Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 36: Japan Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 37: Japan 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 38: Japan Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 39: Japan Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 40: Japan 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
CHINA
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 41: China Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 42: China Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 43: China 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 44: China Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 45: China Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 46: China 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
EUROPE
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 47: Europe Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 48: Europe Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 49: Europe 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 50: Europe Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 51: Europe Historic Review for Optical Preclinical Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 52: Europe 16-Year Perspective for Optical Preclinical Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 53: Europe Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 54: Europe Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 55: Europe 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
FRANCE
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 56: France Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 57: France Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 58: France 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 59: France Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 60: France Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 61: France 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
GERMANY
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 62: Germany Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 63: Germany Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 64: Germany 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 65: Germany Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 66: Germany Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 67: Germany 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
ITALY
- Table 68: Italy Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 69: Italy Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 70: Italy 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 71: Italy Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 72: Italy Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 73: Italy 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 74: UK Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 75: UK Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 76: UK 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 77: UK Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 78: UK Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 79: UK 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
SPAIN
- Table 80: Spain Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 81: Spain Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 82: Spain 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 83: Spain Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 84: Spain Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 85: Spain 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
RUSSIA
- Table 86: Russia Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 87: Russia Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 88: Russia 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 89: Russia Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 90: Russia Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 91: Russia 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 92: Rest of Europe Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 93: Rest of Europe Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 94: Rest of Europe 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 95: Rest of Europe Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 96: Rest of Europe Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 97: Rest of Europe 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 99: Asia-Pacific Historic Review for Optical Preclinical Imaging by End-Use - Pharma & Biotech Companies, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 100: Asia-Pacific 16-Year Perspective for Optical Preclinical Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
- Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 102: Asia-Pacific Historic Review for Optical Preclinical Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 103: Asia-Pacific 16-Year Perspective for Optical Preclinical Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 105: Asia-Pacific Historic Review for Optical Preclinical Imaging by Modality - Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 106: Asia-Pacific 16-Year Perspective for Optical Preclinical Imaging by Modality - Percentage Breakdown of Value Sales for Bioluminescence / Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray / Optical + CT for the Years 2014, 2024 & 2030
AUSTRALIA
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
LATIN AMERICA
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
MIDDLE EAST
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
AFRICA
- Optical Preclinical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BioTek Instruments, Inc.
- Bruker Corporation
- Fujifilm Holdings America Corporation
- Fujifilm Holdings Corporation
- Magnetic Insight, Inc.
- MBF Bioscience
- Mediso Ltd.
- MILabs B.V.
- Miltenyi Biotec
- MR Solutions
- PerkinElmer, Inc.
- TriFoil Imaging
- UVP
- Vieworks Co., Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 93 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 627.4 Million |
| Forecasted Market Value ( USD | $ 936.9 Million |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
